PT-141 (Bremelanotide)

Mass-spec verifiedHPLC ≥99%Endotoxin tested

PT-141 (Bremelanotide) is a cyclic heptapeptide derived from the Melanotan family with selective MC3R/MC4R activity. Research literature investigates PT-141 for central modulation of dopamine and arousal pathways, with FDA approval for hypoactive sexual desire disorder. Standard research dose is approximately 1.75 mg subcutaneous.

$70.00USD per vial

Volume tier — qty 5+: −10% applied at checkout

Specification sheet

Identity: Mass-spec confirmed
Purity (HPLC): ≥99.0%
Endotoxin: <0.25 EU/mg
Storage: −20°C, sealed
Form: Lyophilized powder
Solvent (recom.): 0.6% acetic acid

CoA per lot
Open this lot’s CoA →
Verified ID
Identity confirmed to 4 decimal-place mass
Cold-chain
Vacuum-sealed, temperature-monitored
Use
Research use only · non-human
Shipping
Standard · 5–7 days · flat $10
Return policy
Open-vial exempt · sealed within 30d